OXB Announces Participation in Key Investor Conferences
OXB, a prominent name in the cell and gene therapy sector, has exciting news regarding its active involvement in upcoming investor conferences. With a focus on quality and innovation, OXB (LSE: OXB) continues to be at the forefront of the industry. Members from the senior management team will represent the company, including Dr. Frank Mathias, the Chief Executive Officer, and Dr. Lucy Crabtree, the Chief Financial Officer. Their presence at these prestigious events showcases OXB's commitment to engaging with investors and sharing insights about their groundbreaking work.
Details of Upcoming Conferences
First on the agenda is the Stifel Healthcare Conference scheduled for 11 November 2025. During this conference, OXB’s top management will partake in meaningful discussions, including a fireside chat at 13:20 ET (18:20 GMT). Following closely, the Jefferies Global Healthcare Conference will take place in London on 18 November 2025, where OXB's management is slated to present at 11:30 GMT (06:30 ET). These conferences provide a platform for OXB to highlight its innovative approaches and latest advancements in cell and gene therapies.
Highlighting Upcoming Virtual Events
In addition to in-person conferences, OXB will also participate in the Jefferies C-Suite “Back to School” Fireside Chat on 4 November 2025. This virtual chat is an excellent opportunity for OXB to reach out to investors in a more interactive and accessible format. Attendees can expect an engaging discussion that provides deeper insights into OXB's strategies and future direction.
Access to Webcasts and Presentations
As part of OXB’s commitment to transparency and investor relations, live webcasts and recordings of the presentations will be available. Investors and interested parties can easily access these materials in the Investor Relations section of OXB’s website under ‘Results, Reports, Presentations & Webcasts’. This accessibility underscores OXB's dedication to keeping stakeholders informed and engaged, further bridging the gap between the company and its investors.
Stay Updated with OXB's Events Calendar
For those looking to keep track of all upcoming financial events, OXB encourages visits to their investor calendar, which is meticulously maintained to provide updates on various events and presentations. This proactive communication channel ensures that investors do not miss important opportunities to learn about OXB's growth and future visions.
About OXB
OXB (LSE: OXB) is not just another company; it is a leader in the field of cell and gene therapy. With a rich history spanning over three decades, OXB has made significant contributions to viral vector development, the essential component behind many cell and gene therapies today. Their collaborations with innovative pharmaceutical and biotechnology firms are pivotal, providing specialized expertise in the manufacture of lentivirus, adeno-associated virus (AAV), and adenovirus. OXB's extensive capabilities, coupled with robust quality assurance systems, position them as a reliable partner for clients wanting to advance life-changing therapies.
Headquartered in Oxford, UK, OXB is proud to have facilities that are strategically located across various regions, including technologically advanced manufacturing sites in Lyon and Strasbourg, France, and operational hubs in Bedford, MA, and Durham, NC, USA. Their global reach and unparalleled expertise allow OXB to meet the diverse needs of their clients, ensuring safe and effective product delivery.
For more information on OXB and its groundbreaking work in cell and gene therapy, interested individuals are invited to visit the official OXB website and follow the company on social media for the latest updates.
Frequently Asked Questions
What is the purpose of the upcoming investor conferences?
The conferences aim to share insights about OXB's advancements in cell and gene therapies and foster engagement with investors.
Who from OXB is participating in these events?
Senior management, including CEO Dr. Frank Mathias and CFO Dr. Lucy Crabtree, will represent OXB.
How can I access the presentations from these conferences?
Webcasts and recordings will be available in the Investor Relations section on OXB's website.
What is OXB's role in the cell and gene therapy sector?
OXB is a leader in providing CDMO services, specializing in the development and manufacturing of viral vectors.
Where is OXB headquartered?
OXB is headquartered in Oxford, UK, with additional facilities across Europe and the US.
